Biolinq Safety and Effectiveness Trial
NCT06229743
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
247
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus
Interventions
DEVICE:
Biolinq System
Sponsor
Biolinq Inc.